Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

Similar documents
Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

SUMMARY OF PRODUCT CHARACTERISTICS

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package Leaflet: Information for the User

PACKAGE LEAFLET: INFORMATION FOR THE USER. PEGLAX 10g Powder for oral solution in sachet. Macrogol 4000

Package leaflet: Information for the user

If you need the information on this leaflet in an alternative format, such as large text, or Braille please ring from the UK:

Package Leaflet: Information for the patient. Movicol Ready to Take oral solution in sachet

Read all of this leaflet carefully before you start taking this medicine

Patient Information Leaflet MOVICOL Paediatric Plain 6.9g sachet, powder for oral solution

Package leaflet: Information for users. Imodium 2 mg orodispersible tablets Loperamide hydrochloride

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Dulcolax 5 mg, film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide)

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Imodium 1 mg/5 ml oral solution

TOULARYNX DEXTROMETHORPHAN FORTE 3 mg/ml, syrup Dextromethorphan HBr monohydrate

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Plenvu powder for oral solution Macrogol 3350, sodium ascorbate, sodium sulfate anhydrous, ascorbic acid, sodium chloride and potassium chloride.

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride

Package leaflet: Information for the patient. Pikopil druppels voor oraal gebruik, oplossing, 7.5 mg/ml. Sodium picosulfate

What is in this leaflet

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Package leaflet: Information for the User. Moviprep Orange, powder for oral solution

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

PACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1

1. What Miacalcic is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Package leaflet: Information for the user. Nicotinell Tropisk frukt 4 mg medicated chewing-gum

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

PACKAGE LEAFLET: INFORMATION FOR THE USER

1 What Zofran Suppositories are and what they are used for

Package leaflet: Information for the user

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Hedelix Cough Effervescent Tablets are used to relieve symptoms of chronic inflammatory bronchial conditions; for colds affecting the airways.

PACKAGE LEAFLET: INFORMATION FOR THE USER Valaciclovir Bluefish 1000 mg film-coated tablets Valaciclovir

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

1. What Solpadol is and what it is used for

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

SIOFOR mg film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Package leaflet: Information for the patient. Moventig 12.5 mg film-coated tablets Moventig 25 mg film-coated tablets. naloxegol

Package leaflet: Information for the user. Nicovel Frukt 4 mg medicated chewing-gum. nicotine

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Irbenida H 150mg/12,5mg film-coated tablets

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Package leaflet: Information for the user

2 What you need to know before you use Zofran Suppositories

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

HERNOVIR 200 mg tablets

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol)

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

Package leaflet: Information for the patient

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Package leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate.

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

Package leaflet: Information for the patient

Package leaflet: Information for the user. Zidoval 7.5 mg/g Vaginal Gel Metronidazole

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Package Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

TREANA 5mg and 10mg Film-coated Tablets

Package leaflet: Information for the patient. Metformin Actavis 500 mg and 850 mg filmcoated tablets. metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Metformin HCl Bluefish 500 mg/ 850 mg/ 1000 mg, film-coated tablets metformin hydrochloride

Transcription:

Package leaflet: Information for the user Omnilax 10 g powder for oral solution, sachet Macrogol 4000 Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after 14 days. What is in this leaflet 1. What Omnilax is and what it is used for 2. What you need to know before you take Omnilax 3. How to take Omnilax 4. Possible side effects 5. How to store Omnilax 6. Contents of the pack and other information 1. What Omnilax is and what it is used for Omnilax contains the active substance macrogol 4000 and belongs to a group of medicinal products called osmotically acting laxatives. They work by increasing the water content in the stool which helps to relieve problems caused by very slow bowel movements. Omnilax is not absorbed into the bloodstream or degraded in the body. Omnilax is used to treat constipation in adults and children aged 8 years and above. This medicine is a powder that must be dissolved in a glass of water (at least 50 ml). It usually takes 1 to 2 days before it has any effect. Treatment of constipation with medicinal products should be temporary and only be undertaken in addition to a healthy lifestyle and a healthy diet. Self-treatment of short term constipation should not be carried out for longer than 14 days.you must talk to a doctor if you do not feel better or if you feel worse after 14 days. 2. What you need to know before you take Omnilax Do not take Omnilax: - if you are allergic to macrogol (polyethylene glycol) or any of the other ingredients of this medicine (listed in section 6). 1

- if you have a severe intestinal disease such as: inflammatory bowel disease (e.g. ulcerative colitis, Crohn s disease, abnormal dilation of the bowel) perforation (hole) in the gastrointestinal tract or are at risk of this if you have or suspect a blockage in your intestine if you have abdominal pain of unknown cause. Do not use this medicine if any of the above applies to you. If you are not sure, talk to a doctor or pharmacist before taking this medicine. Warnings and precautions Cases of allergic reactions with rash and swelling of the face and throat (angioedema) have been reported with medicines containing macrogol (polyethylene glycol). Single severe cases of serious allergic reactions have been reported to cause weakness, collapse or breathing difficulties and feeling generally unwell. If you experience any of these symptoms, stop taking Omnilax and seek medical attention immediately. Since Omnilax can sometimes cause diarrhoea, you should talk to your doctor or pharmacist before taking Omnilax if you: - have impaired liver or kidney function - are taking diuretics (water tablets) or are elderly, as you may be at risk of low sodium (salt) or potassium levels in the bloodstream. Other medicines and Omnilax Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Pregnancy and breast-feeding Omnilax can be used during pregnancy and breast-feeding. Driving and using machines Omnilax has no known effect on the ability to drive or use machines. Omnilax contains sorbitol and sulphur dioxide This medicine contains 0.7 mg sorbitol in each sachet. This medicine contains very small amounts of sulphur dioxide (0.007 mg in each sachet). Sulphur dioxide may rarely cause severe hypersensitivity reactions and bronchospasm. 3. How to take Omnilax Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure. Adults and children 8 years and above: The recommended dose is 1-2 sachets per day, taken as a single dose in the morning. The daily dose can be adjusted according to the effect obtained, from 1 sachet every other day (especially in children) to up to a maximum of 2 sachets per day. Dissolve the contents of the sachet in a glass of water (at least 50 ml) and drink. 2

Please note: - It usually takes 24 to 48 hours for Omnilax to work. - In children, the duration of treatment should not exceed 3 months. - After treatment with Omnilax, the improvement of the bowel movements can be maintained by keeping to a healthy lifestyle and diet. - It usually takes 24 to 48 hours for Omnilax to work. - Treatment with Omnilax should not be carried out for longer than 14 days Talk to your doctor if you don t feel better or if you feel worse after 14 days. - After treatment with Omnilax, the improvement of the bowel movements can be maintained by keeping to a healthy lifestyle and diet. If you take more Omnilax than you should Taking too much Omnilax may cause diarrhoea, stomach pains or vomiting. The diarrhoea usually disappears when treatment is stopped or the dose is reduced. If you suffer from severe diarrhoea or vomiting you should contact a doctor as soon as possible as you may require treatment to prevent salt deficiency caused by fluid loss. If you forget to take Omnilax Take the next dose as soon as you remember but do not take a double dose to make up for a forgotten dose. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. The side effects that are usually mild and transient are: In children Common (may affect up to 1 in 10 users): - Abdominal pain - Diarrhoea which may also cause soreness around the back passage (anus) Uncommon (may affect up to 1 in 100 users): - Vomiting - Nausea - Abdominal bloating Not known (frequency cannot be estimated from available data): - Allergic reactions (hypersensitivity) such as rash, itching, hives (urticaria), swelling of the face or throat, breathing difficulties, dizziness or collapse In adults Common (may affect up to 1 in 10 users): - Abdominal pain - Abdominal bloating - Nausea - Diarrhoea Uncommon (may affect up to 1 in 100 users): - Vomiting - Urgent need to empty bowel - Faecal incontinence 3

Not known (frequency cannot be estimated from available data): - Decreased blood levels of sodium which can cause tiredness and confusion, muscle twitching, seizures and coma - Decreased blood levels of potassium which can cause muscle weakness, twitching or abnormal heart rhythm - Dehydration caused by severe diarrhoea especially in the elderly - Allergic reactions (hypersensitivity) such as skin redness, rash, itching, hives (urticaria), swelling of the face or throat, breathing difficulties, dizziness or collapse Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine. 5. How to store Omnilax Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month. Reconstituted solution should be stored well covered in a refrigerator (2 C-8 C) and is stable for 6 hours. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Omnilax contains - The active substance is macrogol. One sachet contains 10 g macrogol. - The other excipients are saccharin sodium (E954) and flavour (orange-grapefruit aroma containing maltodextrin, sorbitol (E420), sulphur dioxide (E220) and gum arabic (E414)). What Omnilax looks like and contents of the pack Off white powder with a taste of orange-grapefruit. Omnilax is available in pack sizes of [pack sizes to be completed nationally] sachets (not subject to medical prescription) and [pack sizes to be completed nationally] sachets (subject to medical prescription). Not all pack sizes may be marketed. Marketing Authorisation Holder Pro Health Pharma Sweden AB Kullagatan 8-10 252 20 Helsingborg Sweden Phone number: +46 721 903655 info@prohealthpharma.se Manufacturer Recipharm Höganäs AB 4

Sporthallsvägen 6 263 34 Höganäs Sweden This leaflet was last revised 19 February 2018 Detailed information on this medicine is available on the website of {name of MS Agency (link)}. 5